PROCEPT BioRobotics (PRCT) Cash from Financing Activities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Cash from Financing Activities for 7 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Financing Activities rose 2.7% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $10.2 million, a 94.25% decrease from a year earlier, with the FY2025 full-year figure at $11.2 million, down 93.79% from the prior year.
• Cash from Financing Activities was $4.5 million for Q2 2026 at PROCEPT BioRobotics, up from $222000.0 in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $170.5 million in Q4 2024 and troughed at -$1.3 million in Q4 2022.
• A 5-year average of $20.4 million and a median of $2.5 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities plunged 304.66% in 2022 and soared 20764.74% in 2023, its largest moves.
• Over 5 years, Cash from Financing Activities stood at -$1.3 million in 2022, then surged by 317.45% to $2.9 million in 2023, then jumped by 5850.03% to $170.5 million in 2024, then sank by 97.4% to $4.4 million in 2025, then increased by 1.26% to $4.5 million in 2026.
• The last three Cash from Financing Activities figures came in at $4.5 million (Q2 2026), $222000.0 (Q1 2026), and $4.4 million (Q4 2025), per Business Quant data.